biomodal vs Parse Biosciences

biomodal logo

biomodal

Reveal the power of the 6-base genome and discover biology in every mode

87 employees · est. 2012 · Cambridge, United Kingdom

VS
Parse Biosciences logo

Parse Biosciences

Scalable Single Cell Sequencing Without the Instrument

133 employees · est. 2018 · Seattle, United States

biomodal is the older company (2012 vs 2018).

Side-by-Side Comparison

biomodal Parse Biosciences
Founded
2012 older 2018
Headquarters
Cambridge, United Kingdom Seattle, United States
Employees
87 133
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Life Sciences, Clean Energy
Funding Stage
Venture round Acquired
Total Funding
Not tracked yet $299.70M
Funding Rounds
1 6
Services
duet multiomics solution evoC, duet multiomics solution +modC, custom multiomic solutions, modality XPLR for explorative research, integrated genetic and epigenetic sequencing Single cell sequencing services, Whole transcriptome analysis, Data analytics for sequencing, Immune profiling (TCR and BCR), Automation of sequencing workflows
Target Customers
research institutions, biotech companies, healthcare providers, clinical researchers, pharmaceutical companies Research laboratories, Biotech companies, Academic researchers, Biomedical scientists, Immunologists
Taxonomy
6-base GenomeMultiomics SolutionsEpigeneticsSingle-base-resolution SequencingCancer ResearchNeurodegenerative Disease +9 Single Cell SequencingCombinatorial CDNA BarcodingBiotechnology StartupCancer ResearchTissue RepairStem Cell Therapy +9
Website
biomodal.com parsebiosciences.com
biomodal logo

About biomodal

biomodal, founded in 2012, is a pioneering company at the forefront of biotech innovation. Specializing in omics-based life sciences technology and analytics, biomodal is known for its duet multiomics solutions that enhance epigenetic data acquisition from minimal DNA samples. This approach allows f...

Parse Biosciences logo

About Parse Biosciences

Parse Biosciences, founded in 2018 and headquartered in the United States, is a dynamic player in the Biotechnology and Life Sciences sectors. With a compelling slogan—"Scalable Single Cell Sequencing Without the Instrument"—the company is focused on revolutionizing single cell sequencing. Its innov...

Also comparing in this category

Comparing more than these two?

Get biomodal, Parse Biosciences and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does biomodal compare?

A PDF of biomodal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

biomodal was founded in 2012, based in Cambridge, United Kingdom, with 87 employees. biomodal, founded in 2012, is a pioneering company at the forefront of biotech innovation. Specializing in omics-based life sciences technology and analytics, biomodal is known for its duet multiomics. Parse Biosciences was founded in 2018, based in Seattle, United States, with 133 employees. Parse Biosciences, founded in 2018 and headquartered in the United States, is a dynamic player in the Biotechnology and Life Sciences sectors. With a compelling slogan—"Scalable Single Cell Sequencing.
biomodal has raised no disclosed funding and Parse Biosciences $299.70M. Latest stage: biomodal Venture round, Parse Biosciences Acquired.
Both work in Biotechnology and Life Sciences and list cancer research among their focus areas.

Compare biomodal with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at biomodal on 15 Jun 2026, and Parse Biosciences on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes